Related Experiment Video
Updated: Jul 12, 2026

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells
Published on: August 17, 2022
Thyroid autoimmunity and cardiovascular diseases
Insights
Thyroid autoimmunity may increase cardiovascular disease risk in some individuals, particularly men. However, its role as a general risk factor and its mechanisms remain unclear.
Area of Science:
- Endocrinology
- Cardiology
- Immunology
Background:
- Thyroid autoantibodies and elevated thyroid-stimulating hormone (TSH) levels are associated with thyroid dysfunction.
- Cardiovascular diseases (CVD) represent a significant global health burden.
- The potential link between thyroid autoimmunity and cardiovascular risk requires further investigation.
Purpose of the Study:
- To investigate the association between thyroid autoantibodies and elevated TSH levels with cardiovascular disease (CVD) indices.
- To determine if thyroid autoimmunity serves as a cardiovascular risk factor.
Main Methods:
- The study analyzed data from two longitudinal population cohorts (totaling over 2000 individuals) followed for 5 years.
- A cross-sectional hospital-based series of myocardial infarction patients and matched controls was also included.
- Thyroid autoantibody status and TSH levels were assessed in relation to cardiovascular events and mortality.
Main Results:
- In one male cohort (55-74 years), cardiovascular deaths were higher in those with thyroid autoantibodies (19%) versus controls (11%).
- In a second, broader cohort (40-64 years), this association was not significant in males but showed a trend in females.
- Elevated TSH levels did not prove to be a better indicator of cardiovascular risk than thyroid autoantibodies.
Conclusions:
- Thyroid autoimmunity may function as a cardiovascular risk factor in specific circumstances.
- The observed association does not indicate general significance for thyroid autoimmunity as a CVD risk factor.
- The underlying mechanisms connecting thyroid autoimmunity to cardiovascular outcomes remain undetermined.
Abstract:
The relationship of thyroid autoantibodies and elevated TSH level to indices of cardiovascular diseases was studied in two population series monitored for 5 years and in a cross-sectional hospital series. In a cohort of 1105 males, initially 55-74 years of age, deaths due to cardiovascular causes occurred in 19% of subjects with thyroid autoantibodies and in 11% of controls matched for age (P less than 0.05). In another cohort of 1045 males and 1223 females, initially 40-64 years of age, no difference emerged in males, while 6 out of 20 females who died of cardiovascular causes had thyroid autoantibodies, compared with 18% in the whole series. In a series of 97 hospital patients with myocardial infarction, 7 patients had thyroid autoantibodies as opposed to 12 antibody-positive subjects among controls matched for age and sex. Elevated TSH level appeared to be no better an indicator of cardiovascular morbidity or mortality than thyroid autoantibodies. It is concluded that thyroid autoimmunity may act as a cardiovascular risk factor under certain circumstances, but it does not have any general significance and the mechanism of action remains unclear.
Related Concept Videos
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
Hyperthyroidism I: Introduction
Hyperthyroidism II: Pathophysiology
Graves' Disease I: Introduction
Graves Disease II: Pathophysiology
Hypothyroidism II: Pathophysiology

